| Name | Title | Contact Details |
|---|
HemCare Health Services (“HHS”) is a Health Information Exchange company. HHS operates a single unified platform enabling the ability to request and retrieve medical information and records while meeting all of today`s Security & Compliance demands for HIPAA, PIPEDA and PHIPA. Through RecordsBank.org, the Company offers an easy to use online portal to our centralized System for Patients, Lawyers & Insurers to Retrieve and Access Medical Records 24 hours a day, 7 days a week. The centralized system and portal for Patients, Lawyers & Insurers to Retrieve and Access Medical Records is a cloud-based PIPEDA & HIPAA compliant network of Providers and Record Requestors. Utilizing a secure platform, providers are able to securely exchange records electronically with third-party requestors. Health care providers with proper authorization can also share records with each other. HHS` Electronic health information exchange (HIE) allows doctors, nurses, pharmacists, other health care providers and patients to appropriately access and securely share a patient`s vital medical information electronically—improving the speed, quality, safety and cost of patient care. Despite the widespread availability of secure electronic data transfer, most Americans` medical information is stored on paper—in filing cabinets at various medical offices, or in boxes and folders in patients` homes. When that medical information is shared between providers, it happens by mail, fax or—most likely—by patients themselves, who frequently carry their records from appointment to appointment. While electronic health information exchange cannot replace provider-patient communication, it can greatly improve the completeness of patient`s records, (which can have a big effect on care), as past history, current medications and other information is jointly reviewed during visits. Appropriate, timely sharing of vital patient information can better inform decision making at the point of care and allow providers to • Avoid readmissions • Avoid medication errors • Improve diagnoses • Decrease duplicate testing • Reduce cost and administration If a practice has successfully incorporated faxing patient information into their business process flow, they might question why they should transition to electronic health information exchange. Many benefits exist with information exchange regardless of the means of which it is transferred. However, the value of electronically exchanging is the standardization of data. Once standardized, the data transferred can seamlessly integrate into the recipients` Electronic Health Record (EHR), further improving patient care. For example: • If laboratory results are received electronically and incorporated into a provider`s EHR, a list of patients with diabetes can be generated. The provider can then determine which of these patients have uncontrolled blood sugar and schedule necessary follow-up appointments. There are currently three key forms of health information exchange that HHS facilitates: • Directed Exchange – ability to send and receive secure information electronically between care providers to support coordinated care • Query-based Exchange – ability for providers to find and/or request information on a patient from other providers, often used for unplanned care • Consumer Mediated Exchange – ability for patients to aggregate and control the use of their health information among providers
Care First EMS is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
DecisionLine Clinical Research is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Synthetic Biologics, Inc. trades on the NYSE MKT, LLC under the symbol "SYN". The Company`s principal executive offices are located in Rockville, MD, and the finance and administrative office is located in Ann Arbor, MI. Synthetic Biologics, Inc. is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Company`s lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection and antibiotic-associated diarrhea (AAD), and SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat the underlying cause of irritable bowel syndrome with constipation (IBS-C). In addition, the Company is developing a monoclonal antibody combination for the treatment of Pertussis, and a Phase 2 oral estriol drug for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS.
Windham Community Memorial Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Windham Community Memorial Hospital is based in Willimantic, CT. You can find more information on Windham Community Memorial Hospital at www.wcmh.org